These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22584465)

  • 1. Uric acid in heart failure: a biomarker or therapeutic target?
    Kaufman M; Guglin M
    Heart Fail Rev; 2013 Mar; 18(2):177-86. PubMed ID: 22584465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
    Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; Beltrami M; Giordano N; Nuti R; McCullough PA
    Am J Cardiol; 2016 May; 117(10):1616-1621. PubMed ID: 27040576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serum insulin on the association between hyperuricemia and incident heart failure.
    Desai RV; Ahmed MI; Fonarow GC; Filippatos GS; White M; Aban IB; Aronow WS; Ahmed A
    Am J Cardiol; 2010 Oct; 106(8):1134-8. PubMed ID: 20920653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction.
    Nishino M; Egami Y; Kawanami S; Sugae H; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
    J Am Heart Assoc; 2022 Oct; 11(19):e026301. PubMed ID: 36129035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
    Kojima S; Sakamoto T; Ishihara M; Kimura K; Miyazaki S; Yamagishi M; Tei C; Hiraoka H; Sonoda M; Tsuchihashi K; Shimoyama N; Honda T; Ogata Y; Matsui K; Ogawa H;
    Am J Cardiol; 2005 Aug; 96(4):489-95. PubMed ID: 16098298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.
    Tedeschi A; Agostoni P; Pezzuto B; Corra' U; Scrutinio D; La Gioia R; Raimondo R; Passantino A; Piepoli MF
    Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):35-45. PubMed ID: 33238740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum uric acid levels and urinary albumin excretion in patients with heart failure.
    Pinelli M; Bindi M; Moroni F; Castiglioni M
    Acta Cardiol; 2008 Apr; 63(2):191-5. PubMed ID: 18468199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia predicts adverse outcomes in patients with heart failure.
    Hamaguchi S; Furumoto T; Tsuchihashi-Makaya M; Goto K; Goto D; Yokota T; Kinugawa S; Yokoshiki H; Takeshita A; Tsutsui H;
    Int J Cardiol; 2011 Sep; 151(2):143-7. PubMed ID: 20542341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure.
    Sakai H; Tsutamoto T; Tsutsui T; Tanaka T; Ishikawa C; Horie M
    Circ J; 2006 Aug; 70(8):1006-11. PubMed ID: 16864933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure.
    Zhou HB; Xu TY; Liu SR; Bai YJ; Huang XF; Zhan Q; Zeng QC; Xu DL
    Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):351-359. PubMed ID: 30795993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?
    Eisen A; Benderly M; Goldbourt U; Haim M
    Clin Cardiol; 2013 Feb; 36(2):110-6. PubMed ID: 23335377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of uric acid in patients with severely decompensated acute heart failure.
    Okazaki H; Shirakabe A; Kobayashi N; Hata N; Shinada T; Matsushita M; Yamamoto Y; Shibuya J; Shiomura R; Nishigoori S; Asai K; Shimizu W
    J Cardiol; 2016 Nov; 68(5):384-391. PubMed ID: 27261247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications.
    Si K; Wei C; Xu L; Zhou Y; Lv W; Dong B; Wang Z; Huang Y; Wang Y; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():770815. PubMed ID: 34867815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure.
    Park HS; Kim H; Sohn JH; Shin HW; Cho YK; Yoon HJ; Nam CW; Hur SH; Kim YN; Kim KB; Park HJ
    Korean J Intern Med; 2010 Sep; 25(3):253-9. PubMed ID: 20830221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.
    Borghi C; Palazzuoli A; Landolfo M; Cosentino E
    Heart Fail Rev; 2020 Jan; 25(1):43-51. PubMed ID: 31745840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.
    Aksenov S; Peck CC; Eriksson UG; Stanski DR
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29488355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.
    Simão AN; Lozovoy MA; Dichi I
    Expert Opin Ther Targets; 2012 Dec; 16(12):1175-87. PubMed ID: 23020656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.